| Market Cap | ₹8,842Cr |
| ROE | 0.00% |
| P/E Ratio(TTM) | 59.18 |
| EPS(TTM) | 24.43 |
| P/B Ratio | 14.58 |
| Dividend Yield | 0.51% |
| Industry P/E | 33.34 |
| Book Value | 99.14 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
| Parent Organisation | Corona Remedies |
| NSE Symbol | CORONA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.29 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.08 | ||
| Wockhardt | NA (0.00%) | -447.63 | ||
| Cohance Lifesciences | NA (0.00%) | 63.14 |